To The Moon

It's a good time to be a chip stock investor. The same can't be said for software stock bulls, and it's all tied to how investors view the two industries in relation to the artificial intelligence...

Over the past week, the situation in the Middle East has presented a state of "extreme stalemate, neither war nor peace." Regarding the Strait of Hormuz, the United States briefly initiated "Operation Liberty" in an attempt to escort trapped vessels out. However, following a strong response from Iran, US President Donald Trump officially announced the suspension of the plan on May 5, citing the "acceptance of Pakistani mediation." During this period, Iranian officials reiterated that the strait would not reopen unless dictated by national will, leaving energy supply chain risks elevated. On May 7, local time, a new round of military conflict erupted between the US and Iran near the Strait of Hormuz. Despite the sudden outbreak of hostilities, US President Donald Trump insisted that the US-

$Gilead Sciences(GILD)$ $Gilead Sciences, Inc.(GILD) Dips -2.42%: Testing Key Support Near $130, Awaiting Rebound Signal Latest Close Data 📉 Closed at $130.40 on 2026-04-27 (ET), down -2.42% for the day. Currently ~17.1% below its 52-week high of $157.29. Core Market Drivers 📰 The stock faced selling pressure amidst broader market volatility. Key drivers include investor focus on the company's pipeline progress and competitive dynamics in the immunology and oncology sectors. Recent capital flow data showed mixed institutional activity with a significant net inflow on 04-22 followed by muted flows. Technical Analysis 📊 Volume: Daily volume of 5.97M shares, with a Volume Ratio of 1.07, indicating average participation. 🟡 MACD: Latest values are DIF:

$Amazon.com(AMZN)$ Amazon is undervalued. It's the cheapest AI stock and a chip AI company. Strong value, worth 375.

Macro Risks Meet Geopolitical Tension: Can Tech Bulls Hold the Line? Consider Microsoft & Berkshire as a Barbell Strategy 🌟🌟🌟 The market is currently facing a dual threat environment testing the resolve of even the most optimistic investors. Warren Buffett has recently issued a sober warning regarding macro risk, preferring a massive cash reserve over overvalued equities. With $Berkshire Hathaway(BRK.B)$ cash pile reaching a record USD 397 billion as of May 2026, the message is clear: the safety net for high growth tech maybe thinner than it appears. Adding to the complexity is a sharp escalation in geopolitical risk. Recent reports of an Iranian attack on UAE ports have rattled glo

The VanEck Semiconductor ETF’s upward move might show signs of fatigue.

Sorry Elon I wasn’t aware of your game. So here’s the case if Elon wins the trial, he gets $134b however OpenAI is a loss making company which recently raised $122b OpenAI literally needs that money to survive. if that money is gone, OpenAI will have to shut down their operations which is not possible. So they can’t give this money to Elon. But Elon must be compensated. so the only option would be equity. MAJOR EQUITY. In openai. the very company he was removed from would be forced to give back what he always deserved.

Artificial-intelligence chatbots have seemingly taken the world by storm. But can they trade like human pros?Not yet, judging by Alpha Arena, a new competition measuring the investing ability of six...

$Novo-Nordisk A/S(NVO)$ is $Meta Platforms, Inc.(META)$ in 2022In 3 years, people will say, " I can't believe you could have bought $NVO for 15 P/E in 2025".Here is my Investment Thesis:🧵A modern building with the name Novo Nordisk in blue text on its facade. A Danish flag with a red background and white cross is flying on a flagpole in front of the building. The sky is clear and blue with some white clouds.1/ GLP1sNVO GLP-1 drugs, like Ozempic and Wegovy, are revolutionary!They fundamentally change how obesity and type 2 diabetes are treated. Instead of just managing symptoms, they target the body’s appetite and insulin regulation, helping patients lose significant weight and improve cardiovascular and me